IP Library › Granted Patent US 11,421,387
Granted Patent B2
US 11,421,387 · App. 16/522,934 · Granted Aug 23, 2022

Tissue product comprising cellulose acetate

Inventors: Charles Stuart Everett (Kingsport, TN); Melvin Glenn Mitchell (Penrose, NC); Kenny Randolph Parker (Afton, TN); Mounir Izallalen (Kingsport, TN); Koushik Ghosh (Kingsport, TN)
D21H27/005D21H11/20D21H15/04D21H15/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,421,387
App. No.
16/522,934
Granted
Aug 23, 2022
Kind
B2
Abstract

A tissue product is provided comprising a wet-laid sheet which comprises cellulosic fibers and cellulose ester staple fibers, wherein the cellulose ester staple fibers are present in an amount sufficient to provide the wet laid-sheet with a lower density and higher thickness at a given basis weight compared to a 100% Cellulose Comparative composition, when processed under similar conditions. The cellulose ester staple fibers can also provide the wet laid-sheet with a higher softness and/or higher water absorbance, compared to a 100% Cellulose Comparative composition, when processed under similar conditions.

Claims (15)

1. A tissue product comprising a wet-laid sheet which comprises cellulosic fibers and cellulose ester staple fibers and has a basis weight of 20 g/m 2 or less, wherein the cellulose ester staple fibers are present in an amount in the range from about 4 to 16 wt %, based on the dry weight of the total fibers, wherein the wet laid-sheet has a lower density and higher thickness at a given basis weight and maintains or has increased Elmendorf tear strength compared to a 100% Cellulose Comparative composition when processed under similar conditions, and wherein the cellulose ester staple fibers have an average denier per filament (DPF) of 1.8 to less than 3.0 and an average cut length of 3 to less than 6 mm, and wherein the cellulose ester staple fibers are crimped and have an average of 5 crimps per inch or more.

2. The tissue product according to claim 1 , wherein the cellulose ester staple fiber has a multi-lobal cross-sectional shape.

3. The tissue product according to claim 1 , wherein the cellulosic fibers and cellulose ester staple fibers are present in a combined amount of 50 wt. % or more, based on the total dry weight of the wet-laid sheet.

4. The tissue product according to claim 1 , wherein the cellulosic fibers and cellulose ester staple fibers are co-refined.

5. The tissue product according to claim 4 , wherein the wet-laid sheet has a density that is 1% or more lower at the same basis weight relative to a 100% Cellulose Comparative composition, when processed under similar conditions.

6. A tissue product comprising a wet-laid sheet which comprises cellulosic fibers and cellulose ester staple fibers and has a basis weight of 20 g/m 2 or less, wherein the cellulose ester staple fibers are present in an amount in the range from about 4 to 16 wt %, based on the dry weight of the total fibers, wherein the wet laid-sheet has a higher Gurley softness and maintains or has increased Elmendorf tear strength compared to a 100% Cellulose Comparative composition when processed under similar conditions, and wherein the cellulose ester staple fibers have an average denier per filament (DPF) of 1.8 to less than 3.0 and an average cut length of 3 to less than 6 mm, and wherein the cellulose ester staple fibers are crimped and have an average of 5 crimps per inch or more.

7. The tissue product according to claim 6 , wherein the cellulose ester staple fiber has a multi-lobal cross-sectional shape.

8. The tissue product according to claim 6 , wherein the cellulosic fibers and cellulose ester staple fibers are present in a combined amount of 50 wt. % or more, based on the total dry weight of the wet-laid sheet.

9. The tissue product according to claim 6 , wherein the cellulosic fibers and cellulose ester staple fibers are co-refined.

10. The tissue product according to claim 9 , wherein the wet-laid sheet has a Gurley softness that is 2% or more higher relative to a 100% Cellulose Comparative composition, when processed under similar conditions.

11. A tissue product comprising a wet-laid sheet which comprises cellulosic fibers and cellulose ester staple fibers and has a basis weight of 20 g/m 2 or less, wherein the cellulose ester staple fibers are present in an amount in the range from about 4 to 16 wt %, based on the dry weight of the total fibers, wherein the wet laid-sheet has higher water absorbance and maintains or has increased Elmendorf tear strength relative to a 100% Cellulose Comparative composition when processed under similar conditions, and wherein the cellulose ester staple fibers have an average denier per filament (DPF) of 1.8 to less than 3.0 and an average cut length of 3 to less than 6 mm, and wherein the cellulose ester staple fibers are crimped and have an average of 5 crimps per inch or more.

12. The tissue product according to claim 11 , wherein the cellulose ester staple fiber has a multi-lobal cross-sectional shape.

13. The tissue product according to claim 11 , wherein the cellulosic fibers and cellulose ester staple fibers are present in a combined amount of 50 wt. % or more, based on the total dry weight of the wet-laid sheet.

14. The tissue product according to claim 11 , wherein the cellulosic fibers and cellulose ester staple fibers are co-refined.

15. The tissue product according to claim 14 , wherein the wet-laid sheet has a water absorbance that is 2% or more higher relative to a 100% Cellulose Comparative composition, when processed under similar conditions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2019
From: EVERETT, CHARLES STUART; MITCHELL, MELVIN GLENN; PARKER, KENNY RANDOLPH; IZALLALEN, MOUNIR; GHOSH, KOUSHIK
To: EASTMAN CHEMICAL COMPANY
Reel/Frame 050611/0360 →
Continuity (2)
Provisional Application 62721828 · Aug 23, 2018
Related Publication 20200063371A1 · Feb 27, 2020